Telomir Pharmaceuticals reports new in vitro data on Telomir-1’s epigenetic activity

Telomir Pharmaceuticals has announced new in vitro data demonstrating that its lead drug candidate, Telomir-1, inhibits three members of the KDM5 histone demethylase family. These enzymes are implicated in silencing tumor suppressor genes and activating inflammatory pathways, processes associated wi…